Showing results (211-220 of 287) with videos related to

Sort By:
Pageof 29
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 7, 2008
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapsesJ Petkau, S C Reingold, U Held, et al.
The New England Journal of Medicine|May 11, 2019
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple SclerosisXavier Montalban, Douglas L Arnold, Martin S Weber, et al.
Multiple Sclerosis and Related Disorders|June 14, 2019
Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study<sup>★★</sup>Aaron E Miller, Patrick Vermersch, Ludwig Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2019
Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale studyRefaat E Gabr, Ivan Coronado, Melvin Robinson, et al.
Journal of Neurology|March 2, 2019
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosisBenjamin Turner, Bruce A C Cree, Ludwig Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2012
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosisAaron E Miller, Paul O'Connor, Jerry S Wolinsky, et al.
Multiple Sclerosis and Related Disorders|May 31, 2016
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studiesMathias Mäurer, Giancarlo Comi, Mark S Freedman, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristicsJ W Lindsey, T F Scott, S G Lynch, et al.
JAMA Neurology|November 25, 2014
Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for managementAnn M Arvin, Jerry S Wolinsky, Ludwig Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx datasetMarcus W Koch, Ester Moral, Luis Brieva, et al.
Pageof 29